Aloxiprin

This MedLibrary.org supplementary page on Aloxiprin is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Aloxiprin
Systematic (IUPAC) name
aluminum 2-acetyloxybenzoate hydroxide
Identifiers
CAS number 9014-67-9
ATC code B01AC15
PubChem 3032790
Chemical data
Formula C18H15O9 
Mol. mass 402.288 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Aloxiprin (or aluminum acetylsalicylate) is a platelet aggregation inhibitor. It is derived from aspirin.[1]

It is also known as "Palaprin Forte".[2]

References

  1. ^ CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56-62. PMID 14024235. 
  2. ^ Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice 22 (9): 392-4. PMID 4876729. 

External links


Wikipedia content modification information:

  • This page was last modified on 1 July 2008, at 21:07.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Aloxiprin".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.